Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

CRO/CMO Services

The following articles are focused on China Contract Research Organizations (CROs) and Contract Manfacturing Organizations (CMOs) offering both clinical and pre-clinical services.  Included are news, deals and company information.

Pharmaron Stages $434 Million Hong Kong IPO, after Completing Shenzhen IPO in January

GenScript Forms Bispecific Partnership with Korea's ABL Bio

Beijing's Fountain Medical Raises $62 Million for Clinical CRO Services

Taimei Technology Raises $212 Million to Advance CRO/Life Science Software

Boji Medical and Great Bay Bio Form JV for Long-Acting Anemia Biologic

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China